B

Brookside Capital Inc

5 employees

They design, implement, and manage custom tailored portfolios of liquid assets for high net worth investors.

Investor insights

Sectors invested in

Biotechnology13
Health Care10
Pharmaceutical7
Therapeutics5
Medical5
Video4
Genetics4
Broadcasting3
Photography3
Media and Entertainment3
Women's3
Health Diagnostics3
Biopharma3
Enterprise Software3
Oncology2
Gene Therapy2
biotechnology1
Anti-infectives1
Orphan and Ultra-orphan Disorders1
InsurTech1

Funding rounds participated in

$47M sweet spot round size

Most of their 31 investments are in rounds between $25M and $60M

Investor type

Investment Bank

Basic info

Industry

investment management

Sectors

Photography
Angel Investment
Biotechnology

Date founded

1989

Investments made

S

SOCAR KOREA raised $59M on November 27, 2015

Investors: SK Group and Brookside Capital Inc

S

SevOne raised $47M on September 23, 2015

Investors: VT Technology Ventures, Bain Capital Ventures, Osage Partners, HarbourVest Partners and Brookside Capital Inc

U

Undisclosed raised $82M on July 23, 2015

Investors: Saban Capital Group and Brookside Capital Inc

V

Voyager Therapeutics, Inc. raised $60M on April 13, 2015

Investors: -, Casdin Capital, LLC and Brookside Capital Inc

R

REGENXBIO Inc. raised $30M on January 21, 2015

Investors: Venrock, F-Prime Capital Partners and Brookside Capital Inc

S

Spark Therapeutics, Inc. raised $73M on May 27, 2014

Investors: T. Rowe Price, Sofinnova Ventures, Russia technology fund, Wellington Management and Brookside Capital Inc

A

Anaplan raised $100M on May 13, 2014

Investors: Coatue Management, Meritech Capital Partners, Shasta Ventures, Salesforce Ventures, Workday, Sands Capital Management, Granite Ventures, DFJ Growth and Brookside Capital Inc

N

NJOY Electronic Cigarettes raised $70M on February 28, 2014

Investors: Brookside Capital Inc

L

Larimar Therapeutics Inc. raised $45M on December 4, 2013

Investors: Alta Partners, RA Capital Management, L.P., Venrock and Brookside Capital Inc

D

Dicerna Pharmaceuticals, Inc. raised $60M on July 31, 2013

Investors: Domain Associates, RA Capital Management, L.P., S.R. One Ltd, Abingworth, Sky Ventures, Omega Funds and Brookside Capital Inc

FAQ